Hikal Ltd.

NSE: HIKAL | BSE: 524735 | ISIN: INE475B01022 | Industry: Pharmaceuticals
| Mid-range Performer
261.1000 1.35 (0.52%)
NSE Sep 05, 2025 13:30 PM
Volume: 131.1K
 

logo
Hikal Ltd.
05 Nov 2020, 12:00AM
261.10
0.52%
ICICI Securities Limited
Q2FY21 revenues grew a decent 15.8% YoY to | 372 crore on the back of 34.1% YoY growth in pharma segment to | 279 crore. Crop protection segment fell 17.9% YoY to | 93 crore due to deferral of | 40 crore worth of shipment to Q3FY21. EBITDA for the quarter came in at | 70 crore, up 19.6% YoY (including Covid related expenses of | 1.1 crore). EBITDA margins expanded 58 bps YoY to 18.8% due to lower staff & other expenses, partly offset by lower gross margins. Adjusted PAT grew 23.8% YoY to | 27 crore in line with operational performance. Delta vis-a-vis EBITDA was due to...
Hikal Ltd. has lost -27.12% in the last 6 Months
More from Hikal Ltd.
Recommended